{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:10:46Z","timestamp":1771600246729,"version":"3.50.1"},"reference-count":43,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Becton Dickinson Biosciences","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"crossref","award":["ANR-15-IDEX-02"],"award-info":[{"award-number":["ANR-15-IDEX-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Centre Hospitalier Universitaire Grenoble Alpes","award":["38RC19.425"],"award-info":[{"award-number":["38RC19.425"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Suspicion of myelodysplastic syndromes (MDS) is the most common reason for bone marrow aspirate in elderly patients. Peripheral blood neutrophil myeloperoxidase expression quantified by flow cytometric analysis might rule out MDS for up to 35% of patients referred for suspected disease, without requiring bone marrow aspiration. Yet laboratory-developed liquid antibody cocktails have practical limitations, because of lack of standardisation and poor stability. This research project aims to estimate the level of agreement and comparative accuracy between a single-use flow cytometry tube of lyophilised reagents (BD Lyotube Stain 468) and its laboratory-developed liquid reagent counterpart in quantifying peripheral blood neutrophil myeloperoxidase expression, among adult patients referred for suspected MDS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>The MPO-MDS-Develop project is a cross-sectional diagnostic accuracy study of two index tests by comparison with a reference standard in consecutive unselected adult patients conducted at a single university hospital. Flow cytometry analysis of peripheral blood samples will be performed by independent operators blinded to the reference diagnosis, using either Lyotube Stain 468 or laboratory-developed liquid reagent cocktail. The reference diagnosis of MDS will be established by cytomorphological evaluation of bone marrow aspirate by two independent haematopathologists blinded to the index test results. Morphologic assessment will be complemented by bone marrow flow cytometric score, karyotype and targeted next-generation sequencing panel of 43 genes, where relevant. The target sample size is 103 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>An institutional review board (Comit\u00e9 de Protection des Personnes Sud Est III, Lyon, France) approved the protocol prior to study initiation (reference number: 2020-028-B). Participants will be recruited using an opt-out approach. Efforts will be made to release the primary results within 6 months of study completion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04399018\">NCT04399018<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-065850","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T16:12:30Z","timestamp":1665159150000},"page":"e065850","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Flow cytometry lyophilised-reagent tube for quantifying peripheral blood neutrophil myeloperoxidase expression in myelodysplastic syndromes (MPO-MDS-Develop): protocol for a diagnostic accuracy study"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct04399018","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Tatiana","family":"Raskovalova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scheffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Tondeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Bulabois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautier","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Planta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Dumestre-Perard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Gonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Garban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Merle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-6586","authenticated-orcid":false,"given":"Jos\u00e9","family":"Labar\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"2022100709051786000_12.10.e065850.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1904794"},{"key":"2022100709051786000_12.10.e065850.2","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(19)30211-X","article-title":"Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states","volume":"7","author":"Gondek","year":"2020","journal-title":"Lancet Haematol"},{"key":"2022100709051786000_12.10.e065850.3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00277-016-2649-3","article-title":"Causes of death in 2877 patients with myelodysplastic syndromes","volume":"95","author":"Nachtkamp","year":"2016","journal-title":"Ann Hematol"},{"key":"2022100709051786000_12.10.e065850.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2018.09.001"},{"key":"2022100709051786000_12.10.e065850.5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.annonc.2020.11.002","article-title":"Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020\u2606","volume":"32","author":"Fenaux","year":"2021","journal-title":"Ann Oncol"},{"key":"2022100709051786000_12.10.e065850.6","first-page":"1293","article-title":"Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004","volume":"91","author":"Bain","year":"2006","journal-title":"Haematologica"},{"key":"2022100709051786000_12.10.e065850.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221534","article-title":"Pain assessment and factors influencing pain during bone marrow aspiration: a prospective study","volume":"14","author":"Gendron","year":"2019","journal-title":"PLoS One"},{"key":"2022100709051786000_12.10.e065850.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(03)00312-9"},{"key":"2022100709051786000_12.10.e065850.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.02.010"},{"key":"2022100709051786000_12.10.e065850.10","article-title":"Myelodysplastic syndromes","volume":"383","author":"Raskovalova","year":"2020","journal-title":"N Engl J Med"},{"key":"2022100709051786000_12.10.e065850.11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.602963","article-title":"Neutrophils: need for standardized nomenclature","volume":"12","author":"McKenna","year":"2021","journal-title":"Front Immunol"},{"key":"2022100709051786000_12.10.e065850.12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-0716-0154-9_16","article-title":"Neutrophil degranulation of azurophil and specific granules","volume":"2087","author":"Bedouh\u00e8ne","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2022100709051786000_12.10.e065850.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.02.014"},{"key":"2022100709051786000_12.10.e065850.14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.202275"},{"key":"2022100709051786000_12.10.e065850.15","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00277-021-04446-7","article-title":"Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study","volume":"100","author":"Raskovalova","year":"2021","journal-title":"Ann Hematol"},{"key":"2022100709051786000_12.10.e065850.16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cyto.b.21603","article-title":"Initial flow cytometric evaluation of the Clearllab lymphoid screen","volume":"94","author":"Hedley","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"2022100709051786000_12.10.e065850.17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cyto.b.21766","article-title":"Detection of minimal residual disease in B cell acute lymphoblastic leukemia using an eight-color tube with dried antibody reagents","volume":"96","author":"Bouriche","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"2022100709051786000_12.10.e065850.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2017.03.011","article-title":"Optimization and testing of dried antibody tube: the EuroFlow LST and PIDOT tubes as examples","volume":"475","author":"van der Velden","year":"2019","journal-title":"J Immunol Methods"},{"key":"2022100709051786000_12.10.e065850.19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cyto.b.21371","article-title":"Stabilization of pre-optimized multicolor antibody cocktails for flow cytometry applications","volume":"92","author":"Chan","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"key":"2022100709051786000_12.10.e065850.20","doi-asserted-by":"crossref","first-page":"n\/a","DOI":"10.1002\/cytob.21154","article-title":"Tandem dyes: stability in cocktails and compensation considerations","volume":"86","author":"Johansson","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"2022100709051786000_12.10.e065850.21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cyto.b.21935","article-title":"A multicenter study evaluation of the ClearLLab 10C panels","volume":"100","author":"Hedley","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"key":"2022100709051786000_12.10.e065850.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7336.539"},{"key":"2022100709051786000_12.10.e065850.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"2022100709051786000_12.10.e065850.24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/cyto.a.23844","article-title":"Standardization of flow cytometric immunophenotyping for hematological malignancies: the FranceFlow group experience","volume":"95","author":"Solly","year":"2019","journal-title":"Cytometry A"},{"key":"2022100709051786000_12.10.e065850.25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cytob.21116","article-title":"Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: proposed practical method","volume":"84","author":"Davis","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"2022100709051786000_12.10.e065850.26","doi-asserted-by":"crossref","DOI":"10.1002\/cyto.b.21751","article-title":"Acceptable \"real-life\" variability for lymphocyte counts by flow cytometry","volume":"96","author":"Ticchioni","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"2022100709051786000_12.10.e065850.27","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21108"},{"key":"2022100709051786000_12.10.e065850.28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.048421"},{"key":"2022100709051786000_12.10.e065850.29","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"2022100709051786000_12.10.e065850.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"2022100709051786000_12.10.e065850.31","doi-asserted-by":"publisher","DOI":"10.1159\/000489042"},{"key":"2022100709051786000_12.10.e065850.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.18556"},{"key":"2022100709051786000_12.10.e065850.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527"},{"key":"2022100709051786000_12.10.e065850.34","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780040112"},{"key":"2022100709051786000_12.10.e065850.35","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.143.1.7063747"},{"key":"2022100709051786000_12.10.e065850.36","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.148.3.6878708"},{"key":"2022100709051786000_12.10.e065850.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90837-8"},{"key":"2022100709051786000_12.10.e065850.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.002"},{"key":"2022100709051786000_12.10.e065850.39","doi-asserted-by":"crossref","first-page":"237437352110698","DOI":"10.1177\/23743735211069810","article-title":"Successful training of patients to intervene in health education and clinical research at Grenoble patient school","volume":"9","author":"Merle","year":"2022","journal-title":"J Patient Exp"},{"key":"2022100709051786000_12.10.e065850.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586"},{"key":"2022100709051786000_12.10.e065850.41","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2022100709051786000_12.10.e065850.42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2021011304","article-title":"Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal","volume":"139","author":"Estey","year":"2022","journal-title":"Blood"},{"key":"2022100709051786000_12.10.e065850.43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3324\/haematol.2019.242677","article-title":"Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study","volume":"106","author":"Vantyghem","year":"2021","journal-title":"Haematologica"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-065850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T16:13:06Z","timestamp":1665159186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-065850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,7]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/bmjopen-2022-065850"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-065850","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}